Predicted to enable cyclin-dependent protein serine/threonine kinase inhibitor activity and protein kinase binding activity. Predicted to be involved in several processes, including autophagic cell death; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; and regulation of phosphorylation. Predicted to act upstream of or within negative regulation of cell cycle G1/S phase transition and sensory perception of sound. Predicted to be located in cytosol and nucleoplasm. Predicted to be part of cyclin D2-CDK4 complex. Predicted to be active in nucleus.
RGD Description
Predicted to enable cyclin-dependent protein serine/threonine kinase inhibitor activity and protein kinase binding activity. Predicted to be involved in several processes, including autophagic cell death; negative regulation of apoptotic process; and regulation of phosphorylation. Predicted to act upstream of or within negative regulation of cell cycle G1/S phase transition and sensory perception of sound. Predicted to be located in cytosol and nucleoplasm. Predicted to be part of cyclin D2-CDK4 complex; PARTICIPATES IN G1/S transition pathway; cell cycle pathway, mitotic; INTERACTS WITH 1,2-dimethylhydrazine; 1,3-dinitrobenzene; bisphenol A.